Colon Cancer Drug: Cheap Drug Stuns Doctors
- A swedish research team has demonstrated that a low dose of aspirin significantly reduces the risk of cancer recurrence following surgery in patients with colorectal cancer who have...
- A new randomized clinical trial, led by researchers at karolinska Institutet and Karolinska University Hospital, has revealed that a low dose of aspirin can halve the risk of...
- Approximately two million people globally receive a colorectal cancer diagnosis annually.
“`html
Aspirin Halves Recurrence Risk in Colorectal Cancer Patients with Specific Genetic Alterations
Table of Contents
Published October 4, 2025, at 23:04:49 UTC
A swedish research team has demonstrated that a low dose of aspirin significantly reduces the risk of cancer recurrence following surgery in patients with colorectal cancer who have specific genetic mutations.
Key Findings of the Study
A new randomized clinical trial, led by researchers at karolinska Institutet and Karolinska University Hospital, has revealed that a low dose of aspirin can halve the risk of recurrence in patients with colon and rectal cancer possessing certain genetic alterations within the PIK3 signaling pathway. The study, funded in part by the Swedish Research Council and the Swedish Cancer Society, reports no conflicts of interest among the researchers.
Approximately two million people globally receive a colorectal cancer diagnosis annually. A significant 20 to 40 percent of these patients develop metastases,complicating treatment and increasing mortality rates (National Cancer Institute).
Prior observational studies hinted at aspirin’s potential to lower the risk of various cancers and possibly reduce recurrence after surgery in colorectal cancer patients with mutations in genes involved in the PIK3 signaling pathway. This new trial provides stronger evidence supporting that connection.
Understanding the PIK3 Signaling Pathway
The PIK3 signaling pathway plays a crucial role in regulating fundamental cellular processes, including growth and division.Mutations within this pathway can disrupt these processes, contributing to uncontrolled cell growth and cancer development (National Cancer Institute - PIK3CA Mutations). Identifying these mutations is key to determining which patients might benefit from aspirin therapy.
The study focused on patients whose tumors exhibited alterations in genes within the PIK3 pathway. These alterations make the cancer cells more susceptible to the effects of aspirin.
Aspirin: Uses, Side Effects, and precautions
Aspirin (acetylsalicylic acid) is a widely used medication known for its pain-relieving, fever-reducing, and anti-inflammatory properties. It belongs to the class of drugs called Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) (Mayo Clinic – Aspirin). Its effects typically begin within 30 minutes.
Beyond pain management, low-dose aspirin is frequently prescribed to prevent blood clots. though, it’s essential to be aware of potential side effects, including stomach problems and an increased risk of bleeding.
Individuals with the following conditions should avoid aspirin:
- Stomach ulcers
- Bleeding disorders
- Asthma
While available over-the-counter in higher doses,aspirin should be used cautiously,especially when combined with other blood-thinning medications or alcohol.
| condition | Aspirin Advice |
|---|---|
| Healthy Adult | Low-dose aspirin may be considered for cardiovascular prevention (consult a doctor). |
| Colorectal Cancer (PIK3 mutation) | Low-dose aspirin may reduce recurrence risk after surgery (as per study findings). |
| Stomach Ulcer | Avoid aspirin. |
| Bleeding Disorder | Avoid aspirin. |